Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population

Table 3 Univariate and multivariate analyses for the training set

Variable	Univariate	Multivariate	HR (95%CI)
Sex	0.525	-	-
Age	0.062	-	-
Albumin	0.816	-	-
Platelet count	0.094	-	-
MELD	0.874	-	-
Tumor size in explant	0.059	-	-
Number of tumors in explant	0.007	NS	-
Microvascular invasion	0.895	-	-
Well/mod differentiation	0.811	-	-
Serum AFP level before LT ( ≥ 400 ng/mL)	0.002	0.012	2.92 (1.487-5.748)
Graft (g)/ESLW	0.083	-	-
Waiting time from listing to transplantation	0.77	-	-
Salvage LT	0.019	0.033	2.08 (1.063-4.081)
Milan criteria	0.052	NS	-
UCSF criteria	0.009	NS	-
Sum of tumor size and number	0.002	0.013	1.15 (1.03-1.28)

MELD: Model for end stage liver disease; Well/mod differentiation: Well or moderate differentiation; CI: Confidence interval; AFP: Alpha fetoprotein; LT: Liver transplantation; ESLW: Estimated standard liver weight; UCSF: University of California at San Francisco.